New York-based Nuvation Bio (NYSE: NUVB) today announced positive pooled data from the pivotal Phase II TRUST-I and TRUST-II ...

US pharma giant Merck & Co announced positive overall survival (OS) results from the final analysis of the Phase III ...

Women’s health focussed company Organon China today revealed that it has entered into license and supply agreements with ...

The protection of intellectual property (IP) rights of foreign pharmaceutical companies in Russia remains complex situation, ...

Among the first presentations at the European Society for Medical Oncology (ESMO) meeting that kicked off today, were results ...

At the ESMO Congress 2024, ICON shared survey findings highlighting concerns among oncology professionals about the impact of ...

The National Institute for Health and Care Excellence (NICE) has recommended access Vabysmo (faricimab) for the treatment of ...

GSK announced positive Phase II results for its mRNA seasonal influenza vaccine, showing strong immune responses against ...

Gilead Sciences’ shares closed up 2.7% at $83.16 yesterday, after it releases positive results of an interim analysis from a ...

On Thursday, the US Food and Drug Administration released a Drug Safety Communication warning that Veozah (fezolinetant), ...

The US Food and Drug Administration (FDA) has approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), the first and ...

Fulcrum Therapeutics' shares fell 61% after its Phase III REACH trial for losmapimod in facioscapulohumeral muscular ...